Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.

Authors
Type
Published Article
Journal
Investigational New Drugs
1573-0646
Publisher
Springer-Verlag
Publication Date
Volume
32
Issue
5
Pages
928–936
Identifiers
DOI: 10.1007/s10637-014-0109-2
PMID: 24829073
Source
Medline

Abstract

Statistics

Seen <100 times